Laser Treatment of Toenail Onychomycosis With a 1064 nm Nd:YAG-laser
Launched by AALBORG UNIVERSITY HOSPITAL · Feb 18, 2022
Trial Information
Current as of May 10, 2025
Completed
Keywords
ClinConnect Summary
This study was carried out as a randomised controlled trial (RCT) including two treatment groups subjected to two different laser treatments. A 1064 nm Nd:YAG-laser (Candela Medical, Ellipse Nordlys (Nd:YAG 1064), USA) was used for all treatments.
Potential subjects were recruited from general practitioners and skin clinics in North Jutland from August 24th, 2021, through December 2021.
All interventions and mycological tests for each subject were performed over the course of one day.
After subjects were included, toenails with a clinical suspicion of onychomycosis (OM) were tested for f...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient (\>18 years)
- • Clinical suspicion of fungal infection in at least one toenail
- • Signed informed consent
- • Sufficient nail material to perform two cultures and one nail clipping
- Exclusion Criteria:
- • Administration of oral antifungal medication in the last 12 months or topical antifungal medication in the last month
- • Diabetes mellitus with associated peripheral artery disease (PAD) or neuropathy
- • Under the influence of alcohol or illegal narcotics
- • Unable to understand written and spoken Danish
About Aalborg University Hospital
Aalborg University Hospital is a leading healthcare institution in Denmark, renowned for its commitment to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital actively engages in innovative studies aimed at improving health outcomes across various medical disciplines. With a focus on collaboration and interdisciplinary approaches, Aalborg University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous clinical trials, ensuring adherence to the highest ethical standards and regulatory requirements. The institution is dedicated to fostering a culture of research excellence, contributing valuable insights to the medical community and enhancing treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, Nordjylland, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials